248 related articles for article (PubMed ID: 10643625)
21. Fibrosis and cirrhosis reversibility: clinical features and implications.
Pinzani M; Vizzutti F
Clin Liver Dis; 2008 Nov; 12(4):901-13, x. PubMed ID: 18984473
[TBL] [Abstract][Full Text] [Related]
22. Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension?
Thabut D; Shah V
J Hepatol; 2010 Nov; 53(5):976-80. PubMed ID: 20800926
[TBL] [Abstract][Full Text] [Related]
23. [Hepatic fibrogenesis].
Loréal O; Clément B; Deugnier Y
Rev Prat; 1997 Mar; 47(5):482-6. PubMed ID: 9138408
[TBL] [Abstract][Full Text] [Related]
24. Hepatic stellate cells as a target for the treatment of liver fibrosis.
Bataller R; Brenner DA
Semin Liver Dis; 2001 Aug; 21(3):437-51. PubMed ID: 11586471
[TBL] [Abstract][Full Text] [Related]
25. Hemodynamics in the isolated cirrhotic liver.
Zipprich A
J Clin Gastroenterol; 2007; 41 Suppl 3():S254-8. PubMed ID: 17975473
[TBL] [Abstract][Full Text] [Related]
26. Hepatic stellate cells in inflammation-fibrosis-carcinoma axis.
Wang BB; Cheng JY; Gao HH; Zhang Y; Chen ZN; Bian H
Anat Rec (Hoboken); 2010 Sep; 293(9):1492-6. PubMed ID: 20652939
[TBL] [Abstract][Full Text] [Related]
27. Hepatic fibrosis -- overview.
Friedman SL
Toxicology; 2008 Dec; 254(3):120-9. PubMed ID: 18662740
[TBL] [Abstract][Full Text] [Related]
28. Hepatic venous pressure gradient and outcomes in cirrhosis.
Ripoll C
J Clin Gastroenterol; 2007; 41 Suppl 3():S330-5. PubMed ID: 17975485
[TBL] [Abstract][Full Text] [Related]
29. Expression of bcl-2 in ductular proliferation is related to periportal hepatic stellate cell activation and fibrosis progression in patients with autoimmune cholestasis.
Sánchez-Muñoz D; Castellano-Megías VM; Romero-Gómez M
Dig Liver Dis; 2007 Mar; 39(3):262-6. PubMed ID: 17270507
[TBL] [Abstract][Full Text] [Related]
30. Protein content of liver lymph in patients with portal hypertension secondary to hepatic cirrhosis.
Dumont AE; Witte CL; Witte MH
Lymphology; 1975 Dec; 8(4):111-3. PubMed ID: 1214504
[TBL] [Abstract][Full Text] [Related]
31. Salviae miltiorrhizae ameliorates cirrhosis and portal hypertension by inhibiting nitric oxide in cirrhotic rats.
Wang H; Chen XP; Qiu FZ
Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):391-6. PubMed ID: 14599946
[TBL] [Abstract][Full Text] [Related]
32. Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography.
Rockey DC
Gastroenterology; 2008 Jan; 134(1):8-14. PubMed ID: 18166342
[TBL] [Abstract][Full Text] [Related]
33. Theoretical and practical considerations in the treatment of portal hypertension secondary to hepatic cirrhosis.
Bizer LS
Am Surg; 1984 Oct; 50(10):524-9. PubMed ID: 6385791
[TBL] [Abstract][Full Text] [Related]
34. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough.
Wiest R; Groszmann RJ
Hepatology; 2002 Feb; 35(2):478-91. PubMed ID: 11826425
[No Abstract] [Full Text] [Related]
35. [Morphofunctional rearrangement of the hepatic vasculature in the pathogenesis of portal hypertension in liver cirrhosis].
Garbuzenko DV
Ter Arkh; 2014; 86(2):90-5. PubMed ID: 24772515
[TBL] [Abstract][Full Text] [Related]
36. [Study of central and porto-hepatic hemodynamics before the surgical treatment of patients with liver cirrhosis and portal hypertension].
Eramishantsev AK; Gogichaĭshvili SSh; Lebezev VM; Kitsenko EA; Dolidze MA
Klin Med (Mosk); 1991 Feb; 69(2):81-3. PubMed ID: 1875671
[TBL] [Abstract][Full Text] [Related]
37. [Hepatic microcirculation--with special emphasis on the microvascular alterations related to the development of portal hypertension and shunt].
Nakata K
Saishin Igaku; 1970 Aug; 25(8):1688-96. PubMed ID: 4917827
[No Abstract] [Full Text] [Related]
38. Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario.
Parola M; Marra F; Pinzani M
Mol Aspects Med; 2008; 29(1-2):58-66. PubMed ID: 18022682
[TBL] [Abstract][Full Text] [Related]
39. Underlying mechanism of portal hypertensive gastropathy in cirrhosis: a hemodynamic and morphological approach.
Curvêlo LA; Brabosa W; Rhor R; Lanzoni V; Parise ER; Ferrari AP; Kondo M
J Gastroenterol Hepatol; 2009 Sep; 24(9):1541-6. PubMed ID: 19743998
[TBL] [Abstract][Full Text] [Related]
40. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.
Carpino G; Franchitto A; Morini S; Corradini SG; Merli M; Gaudio E
Ital J Anat Embryol; 2004; 109(4):225-38. PubMed ID: 15717457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
